Telesis Bio, Inc. (TBIO)
NASDAQ: TBIO · IEX Real-Time Price · USD
0.309
-0.021 (-6.42%)
At close: Apr 19, 2024, 4:00 PM
0.390
+0.081 (26.21%)
After-hours: Apr 19, 2024, 7:46 PM EDT
Telesis Bio Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Telesis Bio.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for Telesis Bio is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Keybanc | Keybanc | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 11, 2023 |
Roth Capital | Roth Capital | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2021 |
SVB Leerink | SVB Leerink | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 3, 2021 |
William Blair | William Blair | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 3, 2021 |
Roth Capital | Roth Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jul 26, 2021 |
Financial Forecast
Revenue This Year
36.21M
from 27.51M
Increased by 31.63%
Revenue Next Year
47.43M
from 36.21M
Increased by 30.99%
EPS This Year
-0.80
from -1.64
EPS Next Year
-0.59
from -0.80
Revenue Forecast
Revenue | 2024 | 2025 |
---|---|---|
High | 37.3M | 48.8M |
Avg | 36.2M | 47.4M |
Low | 34.8M | 45.6M |
Revenue Growth
Revenue Growth | 2024 | 2025 |
---|---|---|
High | 35.5% | 34.8% |
Avg | 31.6% | 31.0% |
Low | 26.5% | 25.8% |
EPS Forecast
EPS | 2024 | 2025 |
---|---|---|
High | -0.82 | -0.61 |
Avg | -0.80 | -0.59 |
Low | -0.76 | -0.57 |
EPS Growth
EPS Growth | 2024 | 2025 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.